American Century Companies Inc Geron Corp Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $59,423 - $111,305	30,164 New	30,164 $96,000
Q4 2022 Feb 13, 2023	SELL	$2.03 - $2.42 $36,235 - $43,197	-17,850 Reduced 46.53%	20,512 $49,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $64,064 - $112,784	38,362 New	38,362 $90,000
Q2 2021 Aug 05, 2021	SELL	$1.25 - $1.83 $13,177 - $19,291	-10,542 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $16,023 - $22,138	10,542 New	10,542 $17,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.